Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |